Cambridge Investment Research Advisors’s Innovator Equity Managed 100 Buffer ETF BFRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.19M Buy
155,053
+44,085
+40% +$1.18M 0.01% 1076
2026
Q1
$2.92M Buy
110,968
+84,030
+312% +$2.25M 0.01% 1299
2025
Q4
$723K Buy
26,938
+8,434
+46% +$225K ﹤0.01% 2388
2025
Q3
$491K Buy
18,504
+4
+0% +$104 ﹤0.01% 2698
2025
Q2
$470K Buy
+18,500
New +$467K ﹤0.01% 2604

Other funds holding BFRZ

Cambridge Investment Research Advisors's BFRZ Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Innovator Equity Managed 100 Buffer ETF (BFRZ) stake by 40% in Q2 2026, buying an estimated $1.18M and bringing the position to 155,053 shares worth $4.19M. The position accounts for 0.01% of the portfolio, ranked #1076.

Cambridge Investment Research Advisors first reported a position in BFRZ in Q2 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold BFRZ as of Q2 2026.

  • Cambridge Investment Research Advisors held 155,053 shares of Innovator Equity Managed 100 Buffer ETF worth $4.19M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 44,085 Innovator Equity Managed 100 Buffer ETF shares in Q2 2026, an estimated $1.18M.
  • Innovator Equity Managed 100 Buffer ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1076 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Managed 100 Buffer ETF in Q2 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Innovator Equity Managed 100 Buffer ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.